A SubQ injection is administered into the fatty layer just beneath the skin using a short insulin needle
When it comes to weight loss medications, coverage can be all over the place too
Unless you have exceptional circumstances (modest weight loss goal, strong lifestyle capacity, history of successful maintenance), assume Retatrutide will be ongoing treatment
Two-day delivery arrived as promised
According to FDA approval data for GLP-1 receptor agonists, semaglutide showed an average weight loss of 15% over 68 weeks in clinical trials
Current UK guidance, including recommendations from the MHRA and NICE, advises against using Ozempic whilst breastfeeding due to insufficient data on its excretion into breast milk and potential effects on nursing infants